eFoodSafety Provides Product Update

Scottsdale, AZ - (WORLD STOCK WIRE) - May 13, 2008 -- eFoodSafety.com, Inc. (OTCBB: EFSF), (www.efoodsafety.com), a researcher, developer, and marketer of whole foods and nutraceutical products, provides its shareholders with an update on its products and product pipeline.

"This is an exciting and active time for eFoodSafety as we recently initiated a comprehensive and robust direct-response campaign for two of our products with two more expected to launch in the coming months," says Patricia Gruden, CEO of eFoodSafety. "In the meantime, we continue our research and development activities for many of our other products. We are committed to focusing our efforts on those products that we believe have the greatest potential to address major health concerns in mass markets."

Ms. Gruden continues, "With so many products in development and others on the market, we believe it is a timely occasion to update our shareholders, consumers, and other interested parties, as to our progress. To facilitate the update, we have provided information on our lead products in development as well as those that are currently on the market."

Lead Products in Research & Development:

-- Citroxin(TM): Most recently, Citroxin was tested for its ability to eradicate the H5N1 strain of the bird flu in chick embryos. The test, conducted at Chulalongkorn University in Thailand, showed 68% efficacy. Based on the success of this initial study, the company will initiate a next round of testing in live animals with forms of flu that closely resemble human strains of the disease. These tests will be conducted at a university in the United States that is nationally recognized for its field studies in bird flu.

According to the World Health Organization, there have been 241 deaths in humans in 382 reported cases of the H5N1 strain of avian influenza worldwide from 2003 to the present. In addition to the
human implications of the virus, bird and farm animals are also at risk from infection. As an early entrant in the market, eFoodSafety recognizes potential to use its formula in the mass market as a solution against the virulent influenza.

-- Citroxin O2(TM): eFoodSafety's researchers have completed the EPA required testing against the six major bacteria: (E-coli, Listeria, Pseudomonas, Salmonella, Staphylococcus, and Streptococcus), as well as the H95N strain of avian influenza. Citroxin O2 is currently being tested on chick embryos at Chulalongkorn University in Thailand.

-- Proxorin(TM): Clinical testing has been initiated for its use as a natural antibiotic/anti-microbial against common bacterial pathogens. This testing is being conducted at a major U.S. university, and the company plans to initiate clinical trials on the formula to determine its efficacy in three to six months. The formula is derived from Citroxin, but differs in its time-release capabilities, which allow it to more effectively deliver its ingredients throughout the body.

As a natural alternative, Proxorin can offer several advantages over common drug-based antibiotics, which dominate the large market. As the company continues to advance the R&D process for this formula, it expects to create various forms of the product, including a trans-dermal cream and a high-potency pill for oral ingestion.

-- Occusyn(TM): Informal human case studies have indicated that Occusyn, an integral component of the company's proprietary Lyme disease protocol, has demonstrated 100% efficacy against Lyme
disease. The company plans to initiate additional human clinical trials within the next six to nine months. Lyme disease costs society approximately $1 billion in direct and indirect costs per
year. With antibiotics currently the treatment of choice for the disease, the company hopes to offer new all-natural advantages to the market in an effort to combat the disease.

-- OraPhyte(TM): U.S. Department of Agriculture tests have shown OraPhyte to be effective at eradicating nematodes, a parasite commonly found in freshwater, marine, and terrestrial environments that are known to be harmful to plants. Three major U.S. universities have conducted year-long agricultural studies on the product, and after their positive experiences in treating nematodes affecting plants or food crops, they have decided to continue testing. Furthermore, a fourth major university will also begin testing the product within its agricultural department undergoing crop-specific research.

Crop damage attributable to nematodes accounts for significant economic losses in the multi-million dollar range. The purpose of the additional testing is to refine the product and further
identify specific uses. The licensing agreement can then be use-specific. The company has been informed that the testing should be completed within the next 3-4 months and anticipates that one or
more licensing agreements may be finalized before year-end.

"In addition to our intensive R&D efforts, eFoodSafety has gained significant traction on the marketing front," Ms. Gruden adds. "We recently launched two direct-response campaigns, a dramatic accomplishment, as we mobilize from an R&D company to an R&D company that also markets its products to consumers."

Products Available to Consumers or Nearing Retail Launch:

-- Cinnergen(TM): The company recently launched a direct-response marketing campaign for Cinnergen(TM) with Respond2 Communications Inc, a leading direct-response agency. The two companies will continue to refine the campaign to achieve maximum results and audience exposure. Shareholders can view the campaign at www.cinnergendirect.com. According to the American Diabetic Association, the annual economic impact of diabetes is over 170 billion dollars annually. Cinnergen presents another option for consumers to help regulate blood sugar levels.

-- Cinnechol(TM): Cinnechol's direct-response marketing campaign also recently launched. The commercial can be viewed at www.cinnechol.com. eFoodSafety continues to work with Respond2
Communications to maximize the effectiveness of the campaign. Given the market pressure on prescription drugs that have come under scrutiny for potential side effects, the company believes
that consumers may be increasingly apt to try all-natural solutions as an alterative.

The results to date of the direct-response campaigns have shown an initial moderate increase in product sales. Review of the data collected to date has indicated that the number of visitors to the
respective internet sites from the commercials has far exceeded expectations. However, the company and Respond2 are making additional modifications to the campaigns to bring about a higher conversion of sales with respect to both internet and call volume received.

-- NumaDerm(TM): In another important development, the company expects the NumaDerm direct-response campaign to launch in the next 1-2 months. The product targets a mass consumer base, and its broad appeal is expected to help the company gain additional traction in its sales.

-- PurEffect(TM): PurEffect will soon be available to consumers through a direct-response marketing campaign that will include celebrity endorsements. As a four-step treatment process for acne,
the product provides a front- to back-end solution.

-- Immune Boost Bars(TM): ImmuneBoost Bars are currently available online at www.immuneboost.com. Through the company's relationship with CPG Focus Consulting, it is in discussions with major national retailers to expand its market presence.

-- Talsyn(TM): Talsyn is currently available to patients through physicians. eFoodSafety has also incorporated Talsyn's formula in some of its other products, such as PurEffect and NumaDerm, to
serve as a complement to help repair scarring.

"It is important to highlight that we are committed to growing and advancing our business as a whole, including both the R&D processes as well as the consumer rollout of our products," concludes Ms. Gruden. "For a company the size of ours to successfully develop, manage, and market such a large and varying suite of products, serves as an indication of the scope of our capabilities and pledge to continue driving growth. We look forward to continuing to update our valued shareholders on a regular basis."

About eFoodSafety.com

eFoodSafety.com, Inc., based in Scottsdale, Arizona, is dedicated to improving health conditions around the world through its innovative technologies. Among eFoodSafety products currently available:

Citroxin(TM): an environmentally safe sporicidal product formulated entirely of food-grade components that kills six major bacteria as well as avian influenza.

Cinnergen(TM): a clinically researched, non-prescription liquid whole food nutritional supplement that promotes healthy glucose metabolism.

Cinnechol(TM): a multi-faceted nutritional supplement specifically designed to naturally promote healthy cholesterol and triglyceride levels without causing any side effects, as well as enhance overall cardiovascular health.

PurEffect(TM): an anti-acne skin care system.

Immune Boost Bar(TM): a non-dairy, no refined sugar, all-natural and comprehensive multi-nutrient product that helps fortify the body's immune system and is available in four delicious flavors: chocolate, oatmeal-raisin, chocolate mint and peanut butter.

Talsyn(TM): a product that has been clinically proven to facilitate and improve the appearance, redness and strength of scars.

Please visit the company's website at: http://www.efoodsafety.com.

Safe Harbor Forward-Looking Statements
Statements contained in this release that are not strictly historical are "forward-looking statements." Such forward-looking statements are sometimes identified by words such as "intends," "anticipates," "believes," "expects," and "hopes." The forward-looking statements are made based on information available as of the date hereof, and the Company assumes no obligation to update such forward-looking statements. Editors and investors are cautioned that such forward-looking statements involve risks and uncertainties that could cause the Company's actual results to differ materially from those in these forward-looking statements. Such risks and uncertainties include but are not limited to demand for the Company's products and services, our ability to continue to develop markets, general economic conditions, our ability to secure additional financing for the Company and other factors that may be more fully described in reports to shareholders and periodic filings with the Securities and Exchange Commission.



Patricia Gruden
efoodsafety.com, Inc.
7702 East Doubletree Ranch Road
Suite 300
Scottsdale, AZ 85258
USA

Phone: 415-884-0348
Fax: 480-348-3999


Source: efoodsafety.com, Inc.
Note: The following press release was submitted by: efoodsafety.com, Inc., and World Stock Wire, Inc. is not liable for the contents of this press release.